MUC4-ErbB2 Oncogenic Complex: Binding studies using Microscale Thermophoresis.

Area of Science:

• Biophysics
• Molecular Biology
• Cancer Research

Background:

• MUC4, a membrane mucin, promotes cancer cell proliferation and migration by interacting with the ErbB2 receptor.
• MUC4 is a therapeutic target in pancreatic cancer due to its neoexpression in preneoplastic lesions.
• The quantitative binding affinity of the MUC4-ErbB2 complex was previously unknown.

Purpose of the Study:

• To characterize the MUC4-ErbB2 interaction using biophysical methods.
• To determine the equilibrium dissociation constants (Kd) for MUC4-ErbB2 complexes.
• To validate the role of MUC4's EGF domains in ErbB2 binding.

Main Methods:

• MicroScale Thermophoresis (MST) was employed for quantitative protein interaction analysis.
• Experiments utilized Chinese Hamster Ovary (CHO) cell lysates containing MUC4 variants (MUC4β and MUC4_EGF3+1+2).
• Equilibrium dissociation constants (Kd) were measured for MUC4-ErbB2 complexes.

Main Results:

• The dissociation constants (Kd) for MUC4β-ErbB2 were determined to be 7-25 nM.
• The dissociation constants (Kd) for MUC4_EGF3+1+2/ErbB2 were found to be 65-79 nM.
• The study confirmed that MUC4's three EGF domains are sufficient for efficient ErbB2 interaction.

Conclusions:

• This research provides novel biophysical insights into the MUC4-ErbB2 interaction.
• The findings support MUC4 as a target for cancer therapeutics, particularly in pancreatic cancer.
• The MST approach is valuable for validating small molecule binding affinities in cancer drug discovery targeting MUC4-ErbB2.